David Leslie, DO
Sports Medicine · Jefferson, LANPI 1033536529
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,400 of the $3,634 with a category attached, or 66.0%. Arthrex accounts for 66.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $2,514 and has fallen 87.8% since, to $307 in 2025. That places this record below the midpoint for sports medicine clinicians in LA, where the typical reported total is $3,045.
Across 18 payments — averaging $201.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Vericel Corporation$388
- Pacira Therapeutics, Inc.$141
- Ossur Americas, Inc.$133
- Johnson & Johnson$130
- Pacira Pharmaceuticals Incorporated$123
- plus $307 from 3 others
What the payments were for
- Food & beverage$1,23434%
- Education$2,40066%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 2 | $2,412 |
| Vericel Corporation | 3 | $388 |
| Pacira Therapeutics, Inc. | 3 | $141 |
| Ossur Americas, Inc. | 1 | $133 |
| Johnson & Johnson | 1 | $130 |
| Pacira Pharmaceuticals Incorporated | 2 | $123 |
| Hydrocision, Inc. | 2 | $111 |
| ALON Medical Technology | 3 | $104 |
| Stryker | 1 | $92 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MACI$264
- Unloader One X$133
- Zilretta$105
- EXPAREL$101
How this compares
$3,634 in reported general payments places this provider in the 50th percentile of 82 sports medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 24 | $430 |
| Diclofenac Sodium | 12 | $313 |
| Meloxicam | 48 | $69 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Jefferson
- Andrew GottschalkJefferson$45K
- Walter ChoateJefferson$13K
- Shannon GoodeJefferson$3K
- Olabode AgajaJefferson$2K
- Felix SavoieNew Orleans$1.4M
- Misty SuriNew Orleans$1.2M
- Michael ObrienNew Orleans$391K
- Brett CascioLake Charles$82K
- Brian GodshawNew Orleans$69K
- Michael LeddyAlexandria$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.